Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age16-75
SponsorUniversity of Miami
About this trial
The purpose of this study is to test the effect of an anti-inflammatory diet tailored for patients living in the United States with Crohn's Disease (CD) on clinical symptoms and disease inflammation and to identify biomarkers of response to dietary therapy.
Eligibility criteria
Qualifiers
Documented diagnosis with Crohn's Disease from medical records.
Ages 16-75
Disqualifiers
Diagnosis of Ulcerative Colitis (UC).
Prior J pouch or diversion
Recent inflammatory bowel disease (IBD) related hospitalizations in the last 4 weeks
Clostridium difficile or enteric infections in the last 4 weeks
Trial design
Treatments tested in this trial
- Catered Anti-Inflammatory Diet
- Diet Guidance for Usual Diet
Treatment groups
122 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Miami
Lead sponsor
United States Department of Defense
Collaborator
Source ClinicalTrials.gov